Hedera Dx News

Lunch Symposium: From Innovation to Clinical Practice - Quality, Robustness, and Readiness of Liquid Biopsy

Webinar: Decentralizing Liquid Biopsy in Oncology - From Innovation to Routine Clinical Practice

Hedera Dx participates in the Swiss artificial intelligence initiative NAIPO

Hedera Dx Secures €15 Million Series A to bring modern cancer care to patients across the globe

Hedera Dx Announces Publication of International, Multicenter, Pan-Cancer Liquid Biopsy Test Panel Analytical Validation in medRxiv

Hedera Dx Expects Increased Liquid Biopsy Adoption With Real-World Data Cancer Registries